Literature DB >> 20654688

Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes.

Mervi E Hyvönen1, Pauliina Saurus, Anita Wasik, Eija Heikkilä, Marika Havana, Ras Trokovic, Moin Saleem, Harry Holthöfer, Sanna Lehtonen.   

Abstract

Podocyte injury plays an important role in the development of diabetic nephropathy. Podocytes are insulin-responsive and can develop insulin resistance, but the mechanisms are unknown. To study the role of CD2-associated protein (CD2AP) in podocyte injury, we performed a yeast two-hybrid screening on a glomerular library, and found that CD2AP bound to SH2-domain-containing inositol polyphosphate 5-phosphatase 2 (SHIP2), a negative regulator of insulin signalling. SHIP2 interacts with CD2AP in glomeruli and is expressed in podocytes, where it translocates to plasma membrane after insulin stimulation. Overexpression of SHIP2 in cultured podocytes reduces Akt activation in response to insulin, and promotes apoptosis. SHIP2 is upregulated in glomeruli of insulin resistant obese Zucker rats. These results indicate that SHIP2 downregulates insulin signalling in podocytes. The upregulation of SHIP2 in Zucker rat glomeruli prior to the age of onset of proteinuria suggests a possible role for SHIP2 in the development of podocyte injury. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654688     DOI: 10.1016/j.mce.2010.07.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  24 in total

Review 1.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

2.  Locus and gene-based GWAS meta-analysis identifies new diabetic nephropathy genes.

Authors:  Mohammad Saeed
Journal:  Immunogenetics       Date:  2017-11-16       Impact factor: 2.846

Review 3.  Weight loss interventions and progression of diabetic kidney disease.

Authors:  Neil G Docherty; Aoife L Canney; Carel W le Roux
Journal:  Curr Diab Rep       Date:  2015-08       Impact factor: 4.810

Review 4.  Lipotoxicity as a trigger factor of renal disease.

Authors:  Adriana Izquierdo-Lahuerta; Cristina Martínez-García; Gema Medina-Gómez
Journal:  J Nephrol       Date:  2016-03-08       Impact factor: 3.902

5.  Insulin signaling: implications for podocyte biology in diabetic kidney disease.

Authors:  Richard Coward; Alessia Fornoni
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

6.  Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.

Authors:  Mervi E Hyvönen; Vincent Dumont; Jukka Tienari; Eero Lehtonen; Jarkko Ustinov; Marika Havana; Hannu Jalanko; Timo Otonkoski; Päivi J Miettinen; Sanna Lehtonen
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

7.  Renopathological Microstructure Visualization from Formalin Fixed Kidney Tissue by Matrix-Assisted Laser/Desorption Ionization-Time-of-Flight Mass Spectrometry Imaging.

Authors:  S Fröhlich; B Putz; H Schachner; D Kerjaschki; G Allmaier; M Marchetti-Deschmann
Journal:  Balkan J Med Genet       Date:  2012-12       Impact factor: 0.519

Review 8.  Podocytes.

Authors:  Jochen Reiser; Mehmet M Altintas
Journal:  F1000Res       Date:  2016-01-28

9.  Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway.

Authors:  P Saurus; S Kuusela; E Lehtonen; M E Hyvönen; M Ristola; C L Fogarty; J Tienari; M I Lassenius; C Forsblom; M Lehto; M A Saleem; P-H Groop; H Holthöfer; S Lehtonen
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.

Authors:  S Kuusela; H Wang; A A Wasik; H Suleiman; S Lehtonen
Journal:  Cell Death Dis       Date:  2016-07-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.